肾嗜酸细胞瘤——在肾切除术后的组织学诊断后进行监测是否有充分的依据。
Renal oncocytoma--are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis.
机构信息
Department of Urology, Tel-Aviv University, Assaf Harofeh Medical Center, Zerifin, Israel.
出版信息
Urol Oncol. 2012 Jul-Aug;30(4):362-8. doi: 10.1016/j.urolonc.2009.11.024. Epub 2010 Feb 20.
INTRODUCTION
Oncocytoma is a benign neoplasm of the kidney and comprises about 12% of all renal masses. A definitive preoperative diagnosis of oncocytoma is currently technically not feasible and its practical implication is controversial.
OBJECTIVES
To analyze the current status of preoperative diagnostic tools for oncocytoma, study the different occurrences of oncocytoma-renal cell carcinoma (RCC) coexistence, including the phenomenon of true hybrid tumors, and investigate the rare reports on the natural history of unresected oncocytoma.
MATERIALS AND METHODS
A PubMed search was performed using the following key word: oncocytoma, renal cell carcinoma, natural history, electron microscopy, and cytogenetics. Medline articles and abstracts prior to August 2009 were reviewed.
RESULTS AND CONCLUSIONS
At the moment, preoperative renal mass biopsy is the only way for prenephrectomy histologic diagnosis of oncocytoma. However, it is expected that some of these biopsies, although suggestive for oncocytoma, will suspect chromophobe RCC. In all the English literature, the number of true ipsilateral synchronous hybrid oncocytoma-RCC tumors is extremely low in comparison with the "pure" oncocytomas being resected worldwide. There is almost no data on the natural history of oncocytoma.
简介
肾嗜酸细胞瘤是肾脏的良性肿瘤,约占所有肾脏肿块的 12%。目前,肾嗜酸细胞瘤的术前明确诊断在技术上尚不可行,其实际意义存在争议。
目的
分析目前用于肾嗜酸细胞瘤的术前诊断工具的现状,研究肾嗜酸细胞瘤-肾细胞癌(RCC)共存的不同发生情况,包括真正混合性肿瘤的现象,并探讨关于未切除肾嗜酸细胞瘤的自然病史的罕见报道。
材料和方法
使用以下关键词在 PubMed 上进行了搜索:嗜酸细胞瘤、肾细胞癌、自然病史、电子显微镜和细胞遗传学。回顾了 2009 年 8 月之前的 Medline 文章和摘要。
结果和结论
目前,术前肾肿块活检是肾切除术前组织学诊断肾嗜酸细胞瘤的唯一方法。然而,预计其中一些活检虽然提示为嗜酸细胞瘤,但将怀疑为嫌色细胞 RCC。在所有的英文文献中,与全世界切除的“纯”嗜酸细胞瘤相比,同侧同步真正混合性嗜酸细胞瘤-RCC 肿瘤的数量极低。关于嗜酸细胞瘤的自然病史几乎没有数据。